Clinical Trial Update: Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy

View source ↗

Summary

A pregnancy registry study of exenatide in women with type 2 diabetes during pregnancy was terminated; the registry tracked birth defects and preterm birth outc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Birth Defects
• Preterm Birth
• Type 2 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: AstraZeneca | Conditions: Birth Defects, Type 2 Diabetes | Status: TERMINATED